Summary & Overview
HCPCS G9663: LDL-C Result ≥ 190 mg/dL
HCPCS Level II code G9663 flags any LDL-C laboratory result greater than or equal to 190 mg/dL, a clinically important threshold associated with markedly increased atherosclerotic cardiovascular disease risk. Nationwide, clear identification of very high LDL-C values supports targeted clinical pathways, population health management, and quality measurement related to lipid control and primary prevention of cardiovascular events. The code standardizes reporting of critical LDL-C laboratory findings across ambulatory and outpatient laboratory settings.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on what the code represents, where the service is typically performed, and why capturing LDL-C >= 190 mg/dL matters for clinical decision-making and care coordination. The publication summarizes expected use cases, common billing considerations, and the types of benchmarks and policy updates that affect reporting of high LDL-C results. It also outlines the clinical context for an LDL-C >= 190 mg/dL threshold and where to look for additional coding and coverage clarifications.
Data not available in the input for associated taxonomies, specific ICD-10 pairings, and payer-specific billing policies.
Billing Code Overview
HCPCS Level II code G9663 represents a laboratory result indicating any LDL-C (low-density lipoprotein cholesterol) value greater than or equal to 190 mg/dL. This code is used to denote a markedly elevated LDL-C measurement that is clinically significant for cardiovascular risk assessment.
-
Service type: Laboratory diagnostic test result interpretation/reporting
-
Typical site of service: Outpatient laboratory, clinic-based laboratory, or other ambulatory blood-draw and testing settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 55-year-old male with a history of obesity and a family history of premature coronary artery disease presents for a cardiovascular risk assessment after routine screening. A fasting lipid panel is ordered; the laboratory reports an LDL-C value of 198 mg/dL. The clinic documents the result in the electronic health record, notifies the patient, and schedules a follow-up visit to review risk-reduction strategies and consider pharmacologic therapy.
The typical clinical workflow: the outpatient primary care or cardiology clinic orders a fasting lipid panel; the patient attends a laboratory draw at an ambulatory clinical laboratory or hospital outpatient drawing station; the lab processes the sample and posts an LDL-C result. When the LDL-C result is >= 190 mg/dL, the laboratory flags the value and the ordering provider is notified per standard workflows. The provider documents the abnormal LDL-C, assigns relevant diagnoses, and coordinates follow-up care including counseling, further testing, and medication management as appropriate.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when unusual effort or time beyond typical is documented for processing or interpretation tasks related to the lab result or patient counseling documentation. |